Castle Biosciences, Inc. provided revenue guidance for the full year 2024. The company anticipates generating between $235-240 million in total revenue in 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.24 USD | -0.74% | -0.37% | +12.33% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.33% | 669M | |
-1.29% | 12.64B | |
-0.47% | 8.46B | |
+22.61% | 5.27B | |
-2.03% | 4.49B | |
-53.56% | 3.11B | |
+19.30% | 2.87B | |
+33.07% | 2.31B | |
-8.42% | 2.23B | |
-3.55% | 1.89B |
- Stock Market
- Equities
- CSTL Stock
- News Castle Biosciences, Inc.
- Castle Biosciences, Inc. Provides Revenue Guidance for the Full Year 2024